Organ Transplantation
Page 1 • 2 itemsGlobal organ transplantation market intelligence: Stay ahead with NovaPharmaNews on advancements, regulatory shifts, and investment opportunities.
OSE Immunotherapeutics' Pegrizeprument (VEL-101) Receives FDA Orphan Drug Designation for Heart Transplant Rejection Prevention
OSE Immunotherapeutics announces FDA Orphan Drug Designation for pegrizeprument (VEL-101) to prevent heart transplant rejection, following liver designation.
TransMedics Unveils New CHOPS Organ Preservation System at ISHLT 2026 Meeting
TransMedics introduces Controlled Hypothermic Organ Preservation System (CHOPS) to expand portfolio and support clinical trials for heart and lung transplants.